Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma
适应性重塑机制及其在青光眼中的治疗潜力
基本信息
- 批准号:10583190
- 负责人:
- 金额:$ 45.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-02 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressApoptoticAstrocytesAxonBAX geneBioenergeticsBlindnessBrainCell SurvivalCellular StressClinicalConnexin 43ConnexinsCouplingDataDendritesDependenceDietary SupplementationDiseaseElectrophysiology (science)Exposure toGlaucomaGlycogenGoalsGrantIndividualInsulin-Like Growth Factor IInterventionKnock-outLightLinkMapsMeasuresMetabolicMetabolic stressMetabolismMicrospheresModelingMouse StrainsMusNational Eye InstituteNatureNerveNerve DegenerationNeuronsOptic DiskOptic NerveOpticsOutcomeOxidative StressPatientsPatternPersonsPhysiologic Intraocular PressurePhysiologicalProcessPublishingPyruvateResourcesRetinaRetinal Ganglion CellsRodentSaimiriSignal TransductionSodium ChannelStressSupplementationTestingTherapeuticTransgenesTransgenic MiceTransgenic OrganismsTranslatingVisionWallerian DegenerationWorkage relatedaxonal degenerationaxonopathycell typeconditional knockoutdietaryimprovedin vivo imaginginnovationneurotransmissionnew therapeutic targetnonhuman primatenovelpreservationpressurepreventprotective effectpublic health relevancerepairedresponserestorationretinal ganglion cell degenerationretinotopicstress reductiontherapeutic evaluationtoolvoltage
项目摘要
PROJECT SUMMARY
Glaucoma blinds through degeneration of retinal ganglion cells (RGCs) and their axons in the optic
projection through sensitivity to intraocular pressure (IOP). Many patients continue to lose vision despite efforts
to manage IOP. Thus, an unmet clinical need is a treatment that addresses RGC degeneration directly. Our
long-term goal is to identify new therapeutic targets based on neuronal repair, protection, and restoration. In
the previous grant cycle, we leveraged transgenic mouse strains to discern interplay between RGC dendritic
pruning, axon degeneration, and astrocyte glia. We discovered two novel forms of adaptive remodeling that
boost and preserve RGC signaling and slow progression. With unilateral IOP elevation, metabolic redistribution
transfers metabolites from the unstressed optic nerve to the retina and nerve challenged by IOP elevation
through astrocyte networks. Conditional knock-out of the gap junction protein connexin 43 (Cx43) uncouples
this network and prevents redistribution. Finally, for individual RGCs exposed to elevated IOP, enhanced
excitability amplifies the light response, even as dendritic complexity diminishes, through reorganization of
voltage-gated sodium channels (NaV) in the unmyelinated axon segment. Both phenomena occur early and
are transient, as are their protective effects. Our objective in this competitive renewal is to build upon these
important results to discern how enhanced excitability and metabolic redistribution mechanistically relate to
axonal and dendritic degeneration and whether they can be enhanced to extend RGC survival. As a corollary,
we will test whether the transient nature of both forms of adaptation arises from metabolic and oxidative stress
to the astrocyte network and if boosting resources exogenously reduces this stress and extends visual
function. This hypothesis is supported by new preliminary data showing a dietary metabolite (pyruvate)
increases astrocyte glycogen in the optic nerve and enhances nerve excitation in response to elevated IOP,
suggesting that the two forms of adaptive remodeling may be linked. In our inducible glaucoma models, we will
utilize a cross-disciplinary approach that combines electrophysiological, cellular and in vivo imaging, and
transgenic tools. Aim 1 will determine the dependence of adaptive remodeling on axonopathy and dendritic
pruning. Aim 2 will characterize the interdependence between metabolic redistribution and enhanced
excitability and whether metabolic redistribution through astrocyte networks maps retinotopically to spatial
sectors of intact RGC axon and dendritic function. Finally, Aim 3 will test whether boosting metabolic
resources reduces astrocyte stress, extends adaptive remodeling, and slows progression in mouse and non-
human primate models of glaucoma. Building from results in the prior grant period, our innovative strategy will
elucidate how two novel, intrinsically compensatory adaptive processes utilize metabolic resources to promote
RGC survival in glaucoma. By translating results to our non-human primate model, we will test the therapeutic
value of targeting enhanced excitability and metabolic redistribution as clinical interventions.
项目摘要
青光眼通过视网膜神经节细胞(RGC)及其轴突的变性而致盲
通过对眼内压(IOP)的敏感性进行预测。许多患者继续失去视力,尽管努力
控制IOP。因此,未满足的临床需求是直接解决RGC变性的治疗。我们
长期目标是确定基于神经元修复、保护和恢复的新的治疗靶点。在
在上一个资助周期中,我们利用转基因小鼠品系来辨别RGC树突状细胞之间的相互作用,
修剪、轴突变性和星形胶质细胞胶质。我们发现了两种新的适应性重塑形式,
增强和保护RGC信号传导并减缓进展。单侧眼压升高,代谢再分布
将代谢物从未受压的视神经转移到视网膜和受到IOP升高挑战的神经
通过星形胶质细胞网络。条件性敲除差距连接蛋白连接蛋白43(Cx43)解偶联
这个网络,防止再分配。最后,对于暴露于升高的IOP的个体RGC,
兴奋性放大光反应,即使树突的复杂性减少,通过重组
电压门控钠通道(NaV)在无髓鞘轴突段。这两种现象都发生在早期,
是短暂的,它们的保护作用也是如此。我们在这次竞争性更新中的目标是建立在这些基础上,
重要的结果,以了解如何增强兴奋性和代谢再分配机制,
轴突和树突变性以及它们是否可以增强以延长RGC存活。作为推论,
我们将测试这两种形式的适应的短暂性是否来自代谢和氧化应激
如果外源性地增加资源可以减少这种压力,
功能这一假设得到了新的初步数据的支持,这些数据显示,
增加视神经中的星形胶质细胞糖原并增强对IOP升高的反应的神经兴奋,
这表明这两种形式的适应性重塑可能是相关的。在我们的诱导型青光眼模型中,我们将
利用结合电生理学、细胞和体内成像的跨学科方法,
转基因工具目的1将确定适应性重塑对轴突病变和树突状细胞的依赖性。
修剪目标2将描述代谢再分配和增强的
兴奋性以及是否通过星形胶质细胞网络的代谢再分布将视网膜定位映射到空间
完整的RGC轴突和树突功能。最后,Aim 3将测试是否促进代谢
资源减少星形胶质细胞压力,延长适应性重塑,并减缓小鼠和非
青光眼的人类灵长类动物模型。根据上一个赠款期的成果,我们的创新战略将
阐明两个新的,内在补偿适应过程如何利用代谢资源,以促进
青光眼中的RGC存活率。通过将结果转化到我们的非人类灵长类动物模型中,我们将测试治疗效果。
靶向增强兴奋性和代谢再分布作为临床干预的价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David J. Calkins其他文献
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
青光眼神经退行性变的研究:机制、挑战与治疗
- DOI:
10.1016/j.preteyeres.2024.101261 - 发表时间:
2024-05-01 - 期刊:
- 影响因子:14.700
- 作者:
Ghazi O. Bou Ghanem;Lauren K. Wareham;David J. Calkins - 通讯作者:
David J. Calkins
M and L cones in macaque fovea connect to midget ganglion cells by different numbers of excitatory synapses
猕猴中央凹的 M 和 L 视锥细胞通过不同数量的兴奋性突触连接到侏儒神经节细胞
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:64.8
- 作者:
David J. Calkins;S. Schein;Y. Tsukamoto;P. Sterling - 通讯作者:
P. Sterling
OPTIC NERVE REGENERATION IN MAMMALS: REGENERATED OR SPARED
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
David J. Calkins - 通讯作者:
David J. Calkins
Ganglion cell circuits in primate fovea
灵长类动物中央凹的神经节细胞回路
- DOI:
10.1007/978-94-011-0507-1_32 - 发表时间:
1995 - 期刊:
- 影响因子:13.7
- 作者:
David J. Calkins;S. Schein;Y. Tsukamoto;P. Sterling - 通讯作者:
P. Sterling
High-resolution matrix-assisted laser desorption ionization–imaging mass spectrometry of lipids in rodent optic nerve tissue
啮齿动物视神经组织脂质的高分辨率基质辅助激光解吸电离成像质谱分析
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:2.2
- 作者:
David M. G. Anderson;Daniel Mills;J. Spraggins;W. Lambert;David J. Calkins;K. Schey - 通讯作者:
K. Schey
David J. Calkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David J. Calkins', 18)}}的其他基金
Retinal Ganglion Cell Replacement in Optic Neuropathies
视神经病变中的视网膜神经节细胞替代
- 批准号:
10239017 - 财政年份:2018
- 资助金额:
$ 45.5万 - 项目类别:
Retinal Ganglion Cell Replacement in Optic Neuropathies
视神经病变中的视网膜神经节细胞替代
- 批准号:
10016302 - 财政年份:2018
- 资助金额:
$ 45.5万 - 项目类别:
Mechanisms of Synaptic Remodeling and Neuronal Self-Repair in Aging and Glaucoma
衰老和青光眼中突触重塑和神经元自我修复的机制
- 批准号:
9181431 - 财政年份:2014
- 资助金额:
$ 45.5万 - 项目类别:
Mechanisms of Synaptic Remodeling and Neuronal Self-Repair in Aging and Glaucoma
衰老和青光眼中突触重塑和神经元自我修复的机制
- 批准号:
8976847 - 财政年份:2014
- 资助金额:
$ 45.5万 - 项目类别:
Role of the Nrf2/ARE pathway in retinal ganglion cells during glaucoma pathogenesis and neuroprotection
Nrf2/ARE 通路在青光眼发病机制和神经保护中视网膜神经节细胞中的作用
- 批准号:
10291073 - 财政年份:2012
- 资助金额:
$ 45.5万 - 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
- 批准号:
10231186 - 财政年份:2012
- 资助金额:
$ 45.5万 - 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
- 批准号:
9982922 - 财政年份:2012
- 资助金额:
$ 45.5万 - 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
- 批准号:
10414846 - 财政年份:2012
- 资助金额:
$ 45.5万 - 项目类别:
Transient Receptor Potential Channels and Neurodegeneration in Glaucoma
青光眼的瞬时受体电位通道和神经变性
- 批准号:
8708867 - 财政年份:2008
- 资助金额:
$ 45.5万 - 项目类别:
Transient Receptor Potential Channels and Retinal Ganglion Cell Death in Glaucoma
青光眼中的瞬时受体电位通道和视网膜神经节细胞死亡
- 批准号:
7870313 - 财政年份:2008
- 资助金额:
$ 45.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 45.5万 - 项目类别:
Research Grant